Novozymes has published its interim report for the first quarter of 2015
Today the company raised its sales and earnings outlook for 2015 due to U.S. dollar appreciation. Currency developments in the first three months of the year have boosted Novozymes’ results. But the strength of the dollar can also have a downside.
April 23 2015
Q1 in line with expectations; 2015 outlook adjusted for currencies
The Novozymes Report 2014
| Copyright © 2015 Novozymes. All Rights Reserved.